KBRA is pleased to announce the assignment of preliminary ratings to 16 classes of ACREC 2026-FL4, a managed CRE CLO securitization with the ability to reinvest principal proceeds for 24 months ...

Linux and open source aren't making headlines at CES 2026, but they're working behind the scenes in embedded, automotive, and ...

With the rise of biologics, precision medicine and AI-driven drug discovery, clinical research has entered a new and complex ...

A biotech specializing in disease diagnostics and tailored treatments is about to test the Hong Kong market's interest in AI-focused healthcare IPOs. Geneplus Technology (Shaoxing) Co. Ltd. provides ...

If you filed on paper last year you'll have to print them out yourself or ask for them, and they won't include all the supplemental forms You can save this article by registering for free here. Or ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...

President Donald Trump on Thursday vowed to begin testing US nuclear weapons “on an equal basis” with Russia and China, heralding a potentially major shift in decades of US policy at a time of growing ...

Sarah Annesley receives funding from ME Research UK, The Judith Jane Mason & Harold Stannett Williams Memorial Foundation and the Medical Research Future Fund (MRFF035120). Scientists in the United ...

Editor’s Note: This article is the result of a partnership between The Post and Courier and CBS News. A federal health agency that has promised to scale back its animal research has drawn the ...

95% of clinical trials fail because animal testing is no substitute for human biology - Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap behind ...